Wells Fargo’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPIX
IC
VCM
PA
BCM
BFM
JGC
Wells Fargo's CPIX Position: Q1 2026 in Review
Wells Fargo opened a new position in Cumberland Pharmaceuticals (CPIX) in Q1 2026: 100 shares worth $325. The stake represents ﹤0.01% of the portfolio and ranks #6431 among its holdings. This is a return to the name: Wells Fargo previously reported a position in CPIX as recently as Q1 2025.
Wells Fargo first reported a position in CPIX in Q1 2020 and has held it in 21 quarters since. The position peaked at $6K in Q2 2021. 29 funds tracked by Wall St. Rank hold CPIX as of Q1 2026.
- Wells Fargo held 100 shares of Cumberland Pharmaceuticals worth $325 as of Q1 2026.
- Cumberland Pharmaceuticals was a new Wells Fargo position in Q1 2026.
- Cumberland Pharmaceuticals made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #6431 holding.
- Wells Fargo first reported a position in Cumberland Pharmaceuticals in Q1 2020 and has held it in 21 quarters since.
- Wells Fargo's Cumberland Pharmaceuticals position peaked at $6K in Q2 2021.
- 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.